PhRMA on drug samples:
According to Johnson, restricting the free samples given to doctors would be “unfortunate and could negatively affect patients who rely upon the $16 billion worth of medicines distributed each year,” which “often serve as a safety net.” He added, “We believe that pharmaceutical companies should not offer or provide anything to doctors that would interfere with the independence of their prescribing practices,” but, “[c]learly, pharmaceutical marketing benefits patients.”
